CD86 and head and neck squamous cell carcinoma: CD28, CD86, CD247, and FASLG have been previously shown to be part of small gene sets that are prognosis-related in HNSCC patients (Zhu et al., 2022; Wang et al., 2022; Chi et al., 2022; de Vos et al., 2020).